Editorial

Neurologist. 2011 Nov;17(6 Suppl 1):S1. doi: 10.1097/NRL.0b013e3182396454.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Humans
  • Neuroprotective Agents / therapeutic use
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology*

Substances

  • Antiparkinson Agents
  • Neuroprotective Agents